(1 - 8 von 9
)
An Evening With Experts: Selecting and Sequencing Therapy ...
events.clinicaloptions.com
Agenda. 7:00 PM - 7:10 PM: Welcome and Introduction Joyce O'Shaughnessy, MD. 7:10 PM - 7:40 PM: CDK4/6 Inhibitors in the Management ...
Iniparib extends overall survival in metastat | EurekAlert!
www.eurekalert.org
· At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Joyce O'Shaughnessy, MD, lead investigator of the ...
New Agents, Combinations Showing Durable Benefit in Triple-Negative...
www.oncnursingnews.com
Expert Joyce O'Shaughnessy discusses current topics in breast cancer, particular the advances and future for triple-negative breast cancer (TNBC).
First-Line Ribociclib/Letrozole Effective in Breast Cancer Across ...www.cancertherapyadvisor.com › ... › SABCS 2021
www.cancertherapyadvisor.com
· ... improvement in long-term survival at 5 and 6 years with ribociclib was observed in all subgroups analyzed,” Joyce O'Shaughnessy, MD, ...
From Concept to Clinical Trial – Finding a Cure for Cancers Affecting ...newsroom.marykay.com › NEWS
newsroom.marykay.com
· Joyce O'Shaughnessy, a medical oncologist who focuses on breast cancer prevention and treatment, was looking for funding for the third and final ...
FDA expands indication of Lilly's Verzenio in advanced breast cancer...
www.pharmafile.com
Pharmafile.com is a leading portal for the … industry, providing industry professionals with pharma news, jobs, events, and service company...
Study of Triple-negative Breast Cancer Is Most Cited in AACR Journal
news.bswhealth.com
... and in the hypothesis that targeting specific mutations in patients' TNBCs will improve patients' outcomes," said Joyce O'Shaughnessy, M.D., ...
The Evolving Treatment Paradigm for Triple Negative Breast Cancer
www.oncnursingnews.com
Breast cancer expert Joyce O'Shaughnessy, MD, discusses the current treatments for metastatic triple negative breast cancer (TNBC) as well ...
sortiert nach Relevanz / Datum